Sanotize Research and Development corp.: Clinical Trials

6 trials sponsored by Sanotize Research and Development corp., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 5, Withdrawn 1
Phase 11Completed 1

Follow Sanotize Research and Development corp.: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute Rhinosinusitis
Nitric Oxide Releasing Solution, Nasal spray with isotonic saline - Recurrent Acute Rhinosinusitis
Phase 2CompletedSanotize Research and Development corp.1622024-01-162026-04-22
Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)
Sterile water foot bath, Nitric Oxide - Verruca Plantaris
Phase 2CompletedSanotize Research and Development corp.202023-08-022024-04-17
Nitric Oxide Footbath for Treatment of Diabetic Foot Ulcers
Nitric Oxide-Releasing Solution, Saline solution, hypotonic - Diabetic Foot Ulcer
Phase 1 / Phase 2CompletedSanotize Research and Development corp.402021-02-232023-05-31
Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection
Nitric Oxide-Releasing Drug - SARS-CoV Infection
Phase 2WithdrawnSanotize Research and Development corp.2021-01-012021-07-16
Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection
NORS (Nitric Oxide Releasing Solution) - Corona Virus Infection
Phase 2CompletedSanotize Research and Development corp.1432020-05-082021-02-10
Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)
Nitric Oxide, Budesonide - Chronic Sinusitis
Phase 2CompletedSanotize Research and Development corp.562019-10-272022-06-30

Conditions studied

Sinusitis (2)  ·  Coronavirus Infections (1)  ·  Diabetic Foot (1)  ·  Recurrence (1)  ·  Rhinosinusitis (1)  ·  Severe Acute Respiratory Syndrome (1)  ·  Warts (1)

Interventions

Nitric Oxide (3)  ·  Budesonide (1)  ·  Saline Solution (1)  ·  Therapeutics (1)  ·  noggin protein (1)

Countries

Canada (5)

Top investigators

Amin Javer, MD (1)  ·  Chris Miller, Ph.D (1)  ·  Jeremy Road, MD (1)  ·  Keith Moore, PHARMMD (1)  ·  Keith Moore, PharmD (1)  ·  Scott Schumacher, MD (1)

Results publications

PMID 41493215